(Q35170266)

English

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581 (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

based on heuristic

inferred from title

Steven R Alberts

8

object named as

Steven Alberts

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Carolyn C Compton

4

object named as

Carolyn C Compton

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Monica Bertagnolli

2

object named as

Monica M Bertagnolli

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Donna Niedzwiecki

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Robert S Warren

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Nancy E Kemeny

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Al Bowen Benson

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

S Gail Eckhardt

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Gity N Porjosh

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

David J Kerr

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Anthony Fields

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Philippe Rougier

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

J Marc Pipas

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Joel H Schwartz

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

James Atkins

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Mark O'Rourke

16

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Michael C Perry

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Richard M Goldberg

18

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Robert J Mayer

19

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Thomas A Colacchio

20

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

11 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3146-3152

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Revised TN categorization for colon cancer based on national survival outcomes data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Systemic therapy for colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Distribution of 111In- and 125I-labeled monoclonal antibody 17-1A in mice bearing xenografts of human pancreatic carcinoma HuP-T4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Regression modelling strategies for improved prognostic prediction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Anti-idiotype immunization of cancer patients: modulation of the immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

13 July 2018

Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

27 September 2018

The hope for today--the promise for tomorrow: will oncologists meet the challenge?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

27 September 2018

The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

27 September 2018

The therapeutic use of the unconjugated monoclonal antibodies (MAb) 17-1A in combination with GM-CSF in the treatment of colorectal carcinoma (CRC).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

27 September 2018

Measuring Follow-Up Completeness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3157980

16 November 2018

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/21747085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21747085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies (MAb 17-1A) for the treatment of patients with metastatic colorectal carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21747085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant therapy for patients with colon and rectum cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21747085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://pubmed.ncbi.nlm.nih.gov/21747085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/21747085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/21747085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2010.32.5357

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35170266&oldid=2111359509"